Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Shares Issued (2020 - 2025)

AVITA Medical (RCEL) has disclosed Shares Issued for 4 consecutive years, with $1000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued fell 99.77% year-over-year to $1000.0, compared with a TTM value of $407000.0 through Dec 2025, down 80.94%, and an annual FY2025 reading of $407000.0, down 80.94% over the prior year.
  • Shares Issued was $1000.0 for Q4 2025 at AVITA Medical, down from $32000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $1.0 million in Q3 2024 and bottomed at $1000.0 in Q1 2022.
  • Average Shares Issued over 4 years is $314214.3, with a median of $171000.0 recorded in 2023.
  • The sharpest move saw Shares Issued skyrocketed 17000.0% in 2023, then tumbled 99.77% in 2025.
  • Year by year, Shares Issued stood at $899000.0 in 2022, then tumbled by 98.33% to $15000.0 in 2023, then soared by 2793.33% to $434000.0 in 2024, then crashed by 99.77% to $1000.0 in 2025.
  • Business Quant data shows Shares Issued for RCEL at $1000.0 in Q4 2025, $32000.0 in Q3 2025, and $11000.0 in Q2 2025.